Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carteolol LA 2% versus timolol LA 0.5% for instillation tolerance in ocular hypertension or open-angle glaucoma
2007-001680-30Phase 4Completed
- Sponsor
- Dr Gerhard Mann
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ocular hypertension and open-angle glaucoma (OAG) comparing Carteolol LA 2% with Timolol LA 0.5% (2 arms). Primary endpoints: Subjective tolerance upon instillation, Glaucoma Symptom Scale symptom assessment and 1 more. Started Aug 2007; status: completed.
02
Drugs
Carteololtimolol
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2007-001680-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001680-30.